Trade Mark Journal No.2025/041 10 October 2025
UK00004269376 25 September 2025 (5)
Mark 1
COGNIVANCE
Mark 2
Cognivance
- Class 5
- Pharmaceutical preparations; Pharmaceutical preparations for the treatment of disorders of the central nervous system; Pharmaceutical preparation for the treatment of ADHD; Pharmaceutical preparation for the treatment of high blood pressure.
Aspire Pharma Limited
Representative: Howes Percival LLP